The direct link between CYP2C19 and longevity is not scientifically established. CYP2C19 is a drug-metabolizing enzyme primarily known for its role in processing medications like clopidogrel, omeprazole, and certain antidepressants. Variants (*2, *3, *17) affect metabolic rate, which is clinically relevant for drug dosing. Some studies have found weak associations between CYP2C19 polymorphisms and age-related conditions such as cardiovascular events or cancer, but effects are small and inconsistent. Longevity is polygenic and heavily influenced by environment, lifestyle, and other genes. The evidence for a direct role of CYP2C19 is therefore unclear. A DNA test can provide insights into medication tolerance, but not life expectancy.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-c72a5e59d514c3821bcf3157